Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A21511 | 25266069 | J Diabetes | Alanine transferase: An independent indicator of adiposity related comorbidity risk in youth. | 2014 | Details |
| A21512 | 25265201 | Nanotoxicology | Intratracheal exposure to multi-walled carbon nanotubes induces a nonalcoholic steatohepatitis-like phenotype in C57BL/6J mice. | 2014 | Details |
| A21513 | 25262992 | Eur J Intern Med | Serum homocysteine levels, oxidative stress and cardiovascular risk in non-alcoholic steatohepatitis. | 2014 | Details |
| A21514 | 25261688 | J Ethnopharmacol | Magnolia officinalis attenuates free fatty acid-induced lipogenesis via AMPK phosphorylation in hepatocytes. | 2014 | Details |
| A21515 | 25261569 | Dis Model Mech | High-fat diet decreases activity of the oxidative phosphorylation complexes and causes nonalcoholic steatohepatitis in mice. | 2014 | Details |
| A21516 | 25260964 | BMC Gastroenterol | Long-term follow-up and liver-related death rate in patients with non-alcoholic and alcoholic related fatty liver disease. | 2014 | Details |
| A21518 | 25259621 | Scand J Gastroenterol | A comparison of FibroMeter™ NAFLD Score, NAFLD fibrosis score, and transient elastography as noninvasive diagnostic tools for hepatic fibrosis in patients with biopsy-proven non-alcoholic fatty liver disease. | 2014 | Details |
| A21519 | 25258410 | Am J Physiol Gastrointest Liver Physiol | Mitigation of autophagy ameliorates hepatocellular damage following ischemia-reperfusion injury in murine steatotic liver. | 2014 | Details |
| A21520 | 25256692 | J Magn Reson Imaging | Associations between histologic features of nonalcoholic fatty liver disease (NAFLD) and quantitative diffusion-weighted MRI measurements in adults. | 2014 | Details |
| A21521 | 25256357 | J Nutr Biochem | Interstrain differences in the progression of nonalcoholic steatohepatitis to fibrosis in mice are associated with altered hepatic iron metabolism. | 2014 | Details |
| A21522 | 25256142 | J Cell Mol Med | ASPP2 attenuates triglycerides to protect against hepatocyte injury by reducing autophagy in a cell and mouse model of non-alcoholic fatty liver disease. | 2014 | Details |
| A21524 | 25254002 | Metabolomics | Role of the tumor suppressor IQGAP2 in metabolic homeostasis: Possible link between diabetes and cancer. | 2014 | Details |
| A21525 | 25253959 | World J Gastroenterol | Serum immunoglobulin A concentration is a reliable biomarker for liver fibrosis in non-alcoholic fatty liver disease. | 2014 | Details |
| A21526 | 25253361 | Saudi J Gastroenterol | The effect of bariatric surgeries on nonalcoholic fatty liver disease. | 2015 | Details |
| A21527 | 25252298 | Anatol J Cardiol | Non alcoholic steatohepatitis is associated with subclinical impairment in left ventricular function measured by speckle tracking echocardiography. | 2014 | Details |
| A21528 | 25252208 | Acta Cir Bras | Duodenal jejunal bypass attenuates non-alcoholic fatty liver disease in western diet-obese rats. | 2014 | Details |
| A21529 | 25252033 | J Clin Lab Anal | Elevation of Serum Levels of Advanced Glycation End Products in Patients With Non-B or Non-C Hepatocellular Carcinoma. | 2014 | Details |
| A21530 | 25251446 | Pediatr Obes | Sonographically measured suprailiac adipose tissue is a useful predictor of non-alcoholic fatty liver disease in obese children and adolescents. | 2014 | Details |
| A21531 | 25251399 | Hepatology | Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease. | 2015 | Details |
| A21532 | 25250770 | PLoS One | Serum complement C3f and fibrinopeptide A are potential novel diagnostic biomarkers for non-alcoholic fatty liver disease: a study in Qingdao Twins. | 2014 | Details |
| A21533 | 25250617 | PLoS One | Consuming more of daily caloric intake at dinner predisposes to obesity. A 6-year population-based prospective cohort study. | 2014 | Details |
| A21534 | 25247408 | Radiology | Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. | 2014 | Details |
| A21535 | 25246029 | Acta Diabetol | Genome-wide analysis of hepatic lipid content in extreme obesity. | 2014 | Details |
| A21536 | 25245380 | Curr Med Chem | Association between polycystic ovary syndrome and metabolic syndrome. | 2014 | Details |
| A21537 | 25245142 | J Proteome Res | Serum metabolite signatures of type 2 diabetes mellitus complications. | 2014 | Details |
| A21538 | 25244504 | Atherosclerosis | Urokinase-type plasminogen activator (uPA) stimulates triglyceride synthesis in Huh7 hepatoma cells via p38-dependent upregulation of DGAT2. | 2014 | Details |
| A21539 | 25243967 | Zhonghua Gan Zang Bing Za Zhi | [Analysis of metabolic risk factors for developing nonalcoholic fatty liver in patients with type 2 diabetes mellitus]. | 2014 | Details |
| A21540 | 25243439 | Hellenic J Cardiol | Evaluation of subclinical left ventricular systolic dysfunction using two-dimensional speckle-tracking echocardiography in patients with non-alcoholic cirrhosis. | 2015 | Details |
| A21541 | 25242225 | Cell Metab | Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes. | 2014 | Details |
| A21542 | 25241989 | Chin J Physiol | Relationship between hemoglobin levels and risk for suspected non-alcoholic fatty liver in Taiwanese adults. | 2014 | Details |
| A21543 | 25241608 | J Clin Res Pediatr Endocrinol | Thyroid function in obese children with non-alcoholic fatty liver disease. | 2014 | Details |
| A21545 | 25241023 | Eur J Nutr | The effect of tomato juice supplementation on biomarkers and gene expression related to lipid metabolism in rats with induced hepatic steatosis. | 2014 | Details |
| A21546 | 25240529 | Surg Obes Relat Dis | PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease. | 2014 | Details |
| A21548 | 25239365 | Surgery | Increasing prevalence of nonalcoholic steatohepatitis as an indication for liver transplantation. | 2014 | Details |
| A21549 | 25238938 | Pathol Res Pract | Histopathological aspects of liver under variable food restriction: has the intense one-week food restriction a protective effect on non-alcoholic-fatty-liver-disease (NAFLD) development? | 2014 | Details |
| A21550 | 25238605 | J Gastroenterol Hepatol | Modest alcohol consumption reduces the incidence of fatty liver in men: a population-based large-scale cohort study. | 2015 | Details |
| A21551 | 25234945 | J Hepatol | Arginase 2 deficiency results in spontaneous steatohepatitis: a novel link between innate immune activation and hepatic de novo lipogenesis. | 2014 | Details |
| A21552 | 25233612 | Adv Clin Chem | Metabolic syndrome in pediatrics. | 2014 | Details |
| A21553 | 25233430 | Biochem Soc Trans | Deciphering non-alcoholic fatty liver disease through metabolomics. | 2014 | Details |
| A21554 | 25233423 | Biochem Soc Trans | Histone variants and lipid metabolism. | 2014 | Details |
| A21555 | 25232454 | World J Hepatol | Circulating microRNAs in patients with non-alcoholic fatty liver disease. | 2014 | Details |
| A21556 | 25232450 | World J Hepatol | Role of adipokines and peroxisome proliferator-activated receptors in nonalcoholic fatty liver disease. | 2014 | Details |
| A21557 | 25232397 | Int J Clin Exp Med | Genetic variation I148M in patatin-like phospholipase 3 gene and risk of non-alcoholic fatty liver disease among Filipinos. | 2014 | Details |
| A21558 | 25232252 | World J Gastroenterol | Management of nonalcoholic fatty liver disease: an evidence-based clinical practice review. | 2014 | Details |
| A21559 | 25232245 | World J Gastroenterol | Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemic. | 2014 | Details |
| A21560 | 25231693 | Endocr J | Circulating progranulin level is associated with visceral fat and elevated liver enzymes: significance of serum progranulin as a useful marker for liver dysfunction. | 2014 | Details |
| A21561 | 25229199 | Pathol Int | Japanese herbal medicines shosaikoto, inchinkoto, and juzentaihoto inhibit high-fat diet-induced nonalcoholic steatohepatitis in db/db mice. | 2014 | Details |
| A21562 | 25225495 | Front Immunol | Extracellular vesicle profiling and their use as potential disease specific biomarker. | 2014 | Details |
| A21563 | 25225347 | Adv Nutr | Modulation of the gut microbiota by nutrients with prebiotic and probiotic properties. | 2014 | Details |
| A21564 | 25224698 | Dig Liver Dis | The efficacy and safety of statins for the treatment of non-alcoholic fatty liver disease. | 2014 | Details |
| A21565 | 25224524 | Gastroenterology | Challenges to liver transplantation and strategies to improve outcomes. | 2014 | Details |
| A21568 | 25222487 | PLoS One | Exposure to a northern contaminant mixture (NCM) alters hepatic energy and lipid metabolism exacerbating hepatic steatosis in obese JCR rats. | 2014 | Details |
| A21569 | 25220580 | Sleep Med Rev | Impact of obstructive sleep apnea treatment by continuous positive airway pressure on cardiometabolic biomarkers: a systematic review from sham CPAP randomized controlled trials. | 2014 | Details |
| A21570 | 25219959 | Expert Opin Pharmacother | Current pharmacotherapy for treating pediatric nonalcoholic fatty liver disease. | 2014 | Details |
| A21571 | 25219574 | Liver Int | Characteristics of hepatic fatty acid compositions in patients with nonalcoholic steatohepatitis. | 2014 | Details |
| A21572 | 25219124 | Zhen Ci Yan Jiu | [Effect of electroacupuncture stimulation of back-shu points on expression of TNF-alpha and lipid peroxidation reaction in the liver tissue in non-alcoholic fatty liver disease rats]. | 2014 | Details |
| A21573 | 25218670 | Clin Gastroenterol Hepatol | Prevalence of suspected nonalcoholic fatty liver disease in Hispanic/Latino individuals differs by heritage. | 2014 | Details |
| A21574 | 25218667 | Clin Gastroenterol Hepatol | Effect of weight loss on magnetic resonance imaging estimation of liver fat and volume in patients with nonalcoholic steatohepatitis. | 2014 | Details |
| A21575 | 25217800 | Exp Mol Pathol | Alcoholic and non-alcoholic steatohepatitis. | 2014 | Details |
| A21576 | 25216251 | PLoS One | IL-1 signaling in obesity-induced hepatic lipogenesis and steatosis. | 2014 | Details |
| A21577 | 25216184 | PLoS One | Non-laboratory-based self-assessment screening score for non-alcoholic fatty liver disease: development, validation and comparison with other scores. | 2014 | Details |
| A21578 | 25215862 | Chem Biol Drug Des | Discovery of a Potent 9-Deazaxanthine-based Agent for the Treatment of Obesity-Related Non-alcoholic Fatty Liver Disease. | 2015 | Details |
| A21579 | 25215659 | Nutrients | Obesity as an emerging risk factor for iron deficiency. | 2014 | Details |
| A21580 | 25214402 | Am J Physiol Gastrointest Liver Physiol | Vitamin D deficiency promotes nonalcoholic steatohepatitis through impaired enterohepatic circulation in animal model. | 2014 | Details |
| A21581 | 25211791 | Practitioner | Improving outcomes for patients with obesity. | 2014 | Details |
| A21582 | 25211789 | Practitioner | Detecting patients with cirrhosis in primary care. | 2014 | Details |
| A21585 | 25206279 | World J Gastroenterol | Osthol attenuates hepatic steatosis via decreased triglyceride synthesis not by insulin resistance. | 2014 | Details |
| A21586 | 25205520 | Biochim Biophys Acta | Creatine reduces hepatic TG accumulation in hepatocytes by stimulating fatty acid oxidation. | 2014 | Details |
| A21588 | 25204761 | BMC Med | Non-invasive score identifies ultrasonography-diagnosed non-alcoholic fatty liver disease and predicts mortality in the USA. | 2014 | Details |
| A21589 | 25203709 | Zhonghua Gan Zang Bing Za Zhi | [Development and evaluation of a high-fat/high-fructose diet-induced nonalcoholic steatohepatitis mouse model]. | 2014 | Details |
| A21590 | 25203315 | Hepatology | ALCAT1 controls mitochondrial etiology of fatty liver diseases, linking defective mitophagy to steatosis. | 2015 | Details |
| A21591 | 25202066 | Anticancer Res | Characterization of non-alcoholic steatohepatitis-derived hepatocellular carcinoma as a human stratification model in mice. | 2014 | Details |
| A21592 | 25200997 | J Endocrinol Invest | Evaluation of serum xenin and ghrelin levels and their relationship with nonalcoholic fatty liver disease and insulin resistance in obese adolescents. | 2014 | Details |
| A21593 | 25198445 | Pediatr Ann | Screening for metabolic and reproductive complications in obese children and adolescents. | 2014 | Details |
| A21595 | 25195642 | Nutrients | Epigenetic mechanisms underlying the link between non-alcoholic fatty liver diseases and nutrition. | 2014 | Details |
| A21596 | 25195551 | J Hepatol | Relationship of vitamin D with insulin resistance and disease severity in non-alcoholic steatohepatitis. | 2014 | Details |
| A21597 | 25195550 | J Hepatol | Incidence of non-alcoholic fatty liver disease in Hong Kong: a population study with paired proton-magnetic resonance spectroscopy. | 2014 | Details |
| A21599 | 25195547 | J Hepatol | Effects of n-3 fish oil on metabolic and histological parameters in NASH: a double-blind, randomized, placebo-controlled trial. | 2014 | Details |
| A21600 | 25195022 | J Chromatogr B Analyt Technol Biomed Life Sci | A validated liquid chromatography tandem mass spectrometry method for simultaneous determination of pioglitazone, hydroxypioglitazone, and ketopioglitazone in human plasma and its application to a clinical study. | 2014 | Details |
| A21601 | 25194749 | Toxicology | Prenatal xenobiotic exposure and intrauterine hypothalamus-pituitary-adrenal axis programming alteration. | 2014 | Details |
| A21602 | 25194181 | Best Pract Res Clin Gastroenterol | Non-alcoholic fatty liver disease, obesity and the metabolic syndrome. | 2014 | Details |
| A21603 | 25194178 | Best Pract Res Clin Gastroenterol | Mechanisms behind the link between obesity and gastrointestinal cancers. | 2014 | Details |
| A21604 | 25193471 | Am J Physiol Heart Circ Physiol | Exercise training reverses endothelial dysfunction in nonalcoholic fatty liver disease. | 2014 | Details |
| A21606 | 25192055 | Ultrastruct Pathol | Dilatation of sinusoidal capillary and swelling of sinusoidal fenestration in obesity: an ultrastructural study. | 2014 | Details |
| A21607 | 25191732 | Probl Radiac Med Radiobiol | Clinical importance of the nonalcoholic fatty liver disease: a review. | 2013 | Details |
| A21608 | 25190263 | Dig Dis Sci | Gaps in recognition and evaluation of incidentally identified hepatic steatosis. | 2014 | Details |
| A21609 | 25189636 | Biomarkers | Progress in the search for circulating biomarkers of nonalcoholic fatty liver disease. | 2014 | Details |
| A21610 | 25189458 | World J Urol | Relationship between non-alcoholic fatty liver disease and benign prostatic hyperplasia/lower urinary tract symptoms: new insights from an Italian cross-sectional study. | 2014 | Details |
| A21611 | 25187371 | Diabetes | PRMT3 regulates hepatic lipogenesis through direct interaction with LXRα. | 2014 | Details |
| A21613 | 25186086 | Aliment Pharmacol Ther | Prognostic value of liver fibrosis and steatosis biomarkers in type-2 diabetes and dyslipidaemia. | 2014 | Details |
| A21614 | 25185870 | Aliment Pharmacol Ther | End-stage methotrexate-related liver disease is rare and associated with features of the metabolic syndrome. | 2014 | Details |
| A21615 | 25185415 | Clin Lab | The significance of serum xanthine oxidoreductase in patients with nonalcoholic fatty liver disease. | 2014 | Details |
| A21616 | 25184298 | PLoS One | Limited utility of plasma M30 in discriminating non-alcoholic steatohepatitis from steatosis--a comparison with routine biochemical markers. | 2014 | Details |
| A21617 | 25183508 | Acta Physiol Hung | Naltrexone attenuates endoplasmic reticulum stress induced hepatic injury in mice. | 2014 | Details |
| A21618 | 25183341 | Trends Endocrinol Metab | Role of metabolic lipases and lipolytic metabolites in the pathogenesis of NAFLD. | 2014 | Details |
| A21619 | 25183267 | J Biomed Sci | Flavonoid ingredients of Ginkgo biloba leaf extract regulate lipid metabolism through Sp1-mediated carnitine palmitoyltranferase 1A up-regulation. | 2014 | Details |
| A21620 | 25182422 | Arch Toxicol | Pregnane X receptor activation and silencing promote steatosis of human hepatic cells by distinct lipogenic mechanisms. | 2014 | Details |
| A21621 | 25180874 | Zhonghua Gan Zang Bing Za Zhi | [Association between APOC3 promoter region polymorphisms and non-alcoholic fatty liver disease]. | 2014 | Details |
| A21622 | 25180626 | Mol Med | Binge alcohol consumption aggravates oxidative stress and promotes pathogenesis of NASH from obesity-induced simple steatosis. | 2014 | Details |
| A21623 | 25176122 | Aliment Pharmacol Ther | Association between aspirin use and the prevalence of nonalcoholic fatty liver disease: a cross-sectional study from the Third National Health and Nutrition Examination Survey. | 2014 | Details |